An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial
乙酰胆碱M1受体正向变构调节剂(TAK-071)治疗伴有认知障碍的帕金森病:一项II期随机临床试验
期刊:Jama Neurology
影响因子:21.3
doi:10.1001/jamaneurol.2024.4519
Shanbhag, Niraj M; Padmanabhan, Jaya L; Zhang, Zheng; Harel, Brian T; Jia, Hongxia; Kangarloo, Tairmae; Yin, Wei; Dowling, Ariel V; Laurenza, Antonio; Khudyakov, Polyna; Galinsky, Kevin; Latzman, Robert D; Simuni, Tanya; Weintraub, Daniel; Horak, Fay B; Lustig, Cindy; Maruff, Paul; Simen, Arthur A